Regarding the relationship between inflammation and clinical outcomes, hs-CRP was associated with different outcomes in DM and non-DM patients in our study, which may be attributed to DM being a multifactorial metabolic disease characterized by a state of sub-clinical inflammation [6, 27]. This evidence concerns the gene CRP and diabetes mellitus.